Alejandra Gurtman
Pfizer (United States)(US)Pfizer (United Kingdom)(GB)
Publications by Year
Research Areas
Respiratory viral infections research, Pneumonia and Respiratory Infections, SARS-CoV-2 and COVID-19 Research, Bacterial Infections and Vaccines, Influenza Virus Research Studies
Most-Cited Works
- → Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine(2020)15,281 cited
- → Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates(2020)2,701 cited
- → Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults(2020)1,577 cited
- → Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents(2021)921 cited
- → Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants(2023)874 cited
- → Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age(2021)616 cited
- → Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults(2023)592 cited